0HIY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Atara Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 4.82 USD -3.46% Market Closed

Market Cap: $34.8m

	Atara Biotherapeutics Inc LSE:0HIY	US
	Scatec ASA LSE:0R3I	NO
N	National Beverage Corp LSE:0K50	US
	OTAQ PLC LSE:OTAQ	UK

Profitability Summary

Atara Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Sustainable 3Y Average Gross Margin

50%

Gross Margin is Increasing

2% > 82%

Exceptional Operating Margin

44%

Negative 3Y Average Operating Margin

-1 281%

Operating Margin is Increasing

-455% > 44%

Healthy Net Margin

27%

Negative 3Y Average Net Margin

-1 294%

Net Margin is Increasing

-374% > 27%

Negative Free Cash Flow Margin

-42%

Negative 3Y Average Free Cash Flow Margin

-938%

Free Cash Flow Margin is Increasing

-394% > -42%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-131%

ROIC is Increasing

-298% > 142%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.